Nektar Therapeutics (NKTR)
42.28
+0.38
(+0.91%)
USD |
NASDAQ |
Dec 31, 16:00
42.26
-0.02
(-0.06%)
After-Hours: 20:00
Nektar Therapeutics EPS Diluted (Quarterly): -1.875 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.747 |
| Lyell Immunopharma, Inc. | -2.126 |
| Owlet, Inc. | 0.1338 |
| Amgen, Inc. | 5.934 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.52M |
| Revenue (Quarterly) | 11.79M |
| Total Expenses (Quarterly) | 47.31M |
| Enterprise Value | 628.34M |
| Gross Profit Margin (Quarterly) | 98.34% |
| Profit Margin (Quarterly) | -301.3% |
| Earnings Yield | -10.78% |
| Normalized Earnings Yield | -10.56 |